Is Ozempic a GLP-1? A Detailed Look at Ozempic and GLP-1 Medications

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic contains semaglutide, a medication that activates GLP-1 receptors in the brain and gut to suppress appetite and promote weight loss. Since its approval by the FDA in 2017 for diabetes, semaglutide has become one of the most researched weight management compounds, with clinical trials showing average weight reductions of 15% over 68 weeks in non-diabetic patients.

What is GLP-1 and How Does It Work in Your Body

GLP-1 stands for glucagon-like peptide-1, a natural hormone your intestines release after eating. This hormone signals your brain that you're satisfied, slows your stomach's emptying, and helps regulate blood sugar levels. By binding to GLP-1 receptors on nerve cells and in the digestive tract, this hormone creates a cascade of effects that reduce hunger signals and increase feelings of fullness with smaller meals.

GLP-1 medications like semaglutide are synthetic versions designed to mimic this natural hormone more potently and for longer periods than your body naturally produces it. The extended action of these compounds means a single weekly injection can maintain appetite suppression throughout the entire week. This sustained receptor activation distinguishes GLP-1 drugs from older weight loss medications that required multiple daily doses or had weaker effects on hunger pathways.

Ozempic vs Compounded Semaglutide: Key Differences

Ozempic is a brand-name medication manufactured by Novo Nordisk, while compounded semaglutide is created by licensed 503A compounding pharmacies following the same chemical formula. Both contain identical active ingredients and work through the same GLP-1 receptor pathway. The primary differences lie in cost, accessibility, and supply chain—branded Ozempic often requires insurance coverage or costs several hundred dollars monthly, whereas PlexusDx's compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required.

Compounded medications from licensed 503A pharmacies undergo rigorous quality testing and must meet pharmaceutical-grade standards for purity and potency. PlexusDx sources all compounded semaglutide from accredited 503A facilities that follow strict USP guidelines. This approach allows patients to access the same therapeutic molecule at a fraction of the branded price while maintaining safety and efficacy standards.

Clinical Evidence Behind GLP-1 Semaglutide for Weight Loss

The STEP trials, which enrolled over 4,500 participants, demonstrated that semaglutide 2.4 mg weekly produced an average weight loss of 15.3% of body weight compared to 2.6% with placebo over 68 weeks. These landmark studies showed that GLP-1 receptor agonists work by addressing the biological drivers of obesity rather than relying on willpower alone. Participants also experienced improvements in waist circumference, blood pressure, and metabolic markers independent of weight loss.

Beyond weight reduction, GLP-1 medications improve cardiovascular outcomes and reduce the risk of major adverse cardiac events in patients with existing heart disease or high cardiovascular risk. Recent data from the SUSTAIN 6 trial showed that semaglutide reduced the risk of heart attack, stroke, and cardiovascular death by 26% compared to placebo. These findings underscore why GLP-1 therapy has become standard treatment for type 2 diabetes and is increasingly prescribed off-label for weight management in eligible patients.

Personalized GLP-1 Treatment with Genetic Testing at PlexusDx

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

By understanding your genetic predispositions, PlexusDx clinicians can recommend whether semaglutide injection, oral semaglutide, tirzepatide, or a dual-compound approach will likely work best for your unique physiology. The Precision Peptide Genetic Test is $298 and can be added to your treatment plan after your first month, allowing you to optimize your therapy based on science rather than trial and error. This personalized approach increases the likelihood of sustained weight loss and better tolerability.

Why Choose PlexusDx for Your GLP-1 Treatment

PlexusDx serves all 50 states with no insurance requirement, no membership fees, and HSA/FSA eligibility, making GLP-1 therapy accessible regardless of your insurance status. Compounded semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan) across a flat monthly pricing structure—your dose may need to go up, but your price won't. This transparent approach eliminates the surprise price jumps patients often face with branded medications or dose-dependent pricing schemes.

Every medication from PlexusDx originates from licensed 503A compounding pharmacies that meet rigorous quality and safety standards. PlexusDx combines pharmaceutical expertise with personalized genetic insights to create a treatment experience focused on your individual success. Whether you choose semaglutide injection, oral semaglutide, tirzepatide, or the innovative GLP-Squared dual-compound option, PlexusDx provides the guidance and affordable access needed to achieve meaningful, sustainable weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is Ozempic the same as all GLP-1 medications?

Ozempic is a brand-name GLP-1 medication containing semaglutide, but it's not the only GLP-1 available. Other GLP-1s include tirzepatide (Mounjaro) and liraglutide (Saxenda). PlexusDx offers compounded versions of semaglutide and tirzepatide with identical active ingredients to their branded counterparts, giving you more options at lower costs.

How much weight can I expect to lose with semaglutide?

Clinical trials show average weight loss of 15-22% of body weight over 68 weeks with semaglutide at the 2.4 mg dose, though individual results vary based on genetics, lifestyle, and starting weight. Your response depends partly on genetic variants in your GLP-1 receptor and other metabolic genes that PlexusDx's Precision Peptide Genetic Test can identify.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx's compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat monthly pricing across three commitment tiers—there's no increase as your dose increases. No insurance is required, and the medication is HSA/FSA eligible, making it accessible and affordable for most patients.

Are compounded GLP-1 medications as safe as branded Ozempic?

Compounded semaglutide from licensed 503A pharmacies contains the identical active molecule as Ozempic and undergoes the same quality testing for purity and potency. PlexusDx sources all compounded medications from accredited facilities meeting USP pharmaceutical standards, ensuring safety equivalent to branded versions at a lower cost.

Can genetic testing help me choose the right GLP-1 medication?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in GIPR and FTO, and MC4R genes that influence how your body responds to GLP-1 therapy. The $298 test, added after your first month, identifies which of PlexusDx's options—semaglutide, tirzepatide, or dual-compound therapy—will likely work best for your genetics.

Related Reading

• Glp 1 Medications
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications
• Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications
• Maximus Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.